Endothelial adrenoceptors

Journal of Cardiovascular Pharmacology

Volumn 38, Issue 5, 2001, Pages 796-808

  Vanhoutte, P M ^a  

^a IRIS Institut de Recherches Internationales Servier   (France)

Author keywords

Adrenoceptors; Adrenoceptors; Blockers; Cyclic adenosine monophosphate; Cyclic guanosine monophosphate; Endothelial cells; Endothelium derived relaxing factors; Nitric oxide; Phosphodiesterase III

Indexed keywords

ACETYLCHOLINE; ADENOSINE; ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ARGININE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRIMONIDINE; CYCLIC AMP; CYCLIC GMP; ISOPRENALINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NORADRENALIN; PHENYLEPHRINE; PRAZOSIN; PROPRANOLOL; PROSTAGLANDIN F;

ANIMAL TISSUE; ATHEROSCLEROSIS; DRUG ACTIVITY; ENDOTHELIUM; ENZYME INHIBITION; FOREARM; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VASODILATATION;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; AUTACOIDS; BENZOPYRANS; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; ETHANOLAMINES; HUMANS; MODELS, CHEMICAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENYLEPHRINE; RECEPTORS, ADRENERGIC; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 0034770633     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200111000-00016     Document Type: Review

References (138)

1. Endothelium-derived relaxing and contracting factors
2. Endothelial dysfunction in hypertension
3. Modulation of vascular smooth muscle contraction by the endothelium
4. α2-adrenoceptors and endothelium-derived relaxing factor
5. Interactions of nitric oxide synthase inhibitors and dexamethasone with alphaadrenoceptor-mediated responses in rat aorta
6. Enhancement responsiveness of vascular smooth muscle to vasoconstrictor agents after removal of endothelial cell
7. Role of the endothelium on the response to adrenoceptor agonists of rabbit aorta during cooling
8. Enhancement of alpha-1 and alpha-2 adrenergic agonists induced vasoconstriction by removal of endothelium in rat aorta
9. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin
10. Endothelial cell loss enhances the pressor response in resistance vessels
11. Endothelium modulates the effects of α-adrenoceptor agonists in vascular smooth muscle
12. Endothelial modulation of contractile responses in arteries from hypertensive rats
13. Enhanced responsiveness of rat isolated aorta to clonidine after removal of the endothelial cells
14. Vascular reactivity in diabetes mellitus: Role of the endothelial cells
15. 2-adrenergic constriction in the canine epicardial coronary microcirculation
16. Effect of removing endothelial cells on the reactivity of rat aortic segments to different α-adrenoceptor agonists
17. Endotheliumdependent responses in normotensive and hypertensive Dahl rats
18. Effect of endothelium on basal and α-adrenoceptor stimulated calcium fluxes in rat aorta
19. Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor
20. Unaltered endothelium-dependent modulation of contraction in the pulmonary artery of hypertensive rats
21. Endothelial mediated inhibition of contraction and increase in cyclic GMP levels evoked by the α-adrenoceptor agonist B-HT 920 in rat isolated aorta
22. 2-adrenergic stimulation in systemic canine arteries and veins
23. 2-adrenoceptors in canine pulmonary and systemic blood vessels
24. Potentiation of cyclic AMP-mediated vasorelaxation by phenylephrine in pulmonary arteries of the rat
25. Modeling the changes due to the endothelium and hypertension in the (α-adrenoreceptor-mediated responses of rat aorta
26. Increased vascular responsiveness to norepinephrine in rats with heart failure is endothelium dependent: Dissociation of basal and stimulated nitric oxide release
27. Gender differences in the endothelial regulation of α2-adrenoceptor-mediated contraction in the rat aorta
28. Cyclic GMP modulators on vascular adrenergic neurotransmission
29. Endothelium removal enhances norepinephrine vasoconstriction
30. 2-adrenoceptor agonistinduced contraction in rat mesenteric artery upon removal of endothelium
31. Removal of endothelium reduces β-adrenergic dilation and enhances α-adrenergic constriction in iliac arteries of conscious dogs
32. 2-adrenoceptor activation
33. 2-adrenoceptor and NPY receptor-mediated contractions of porcine isolated blood vessels: Evidence for involvement of the vascular endothelium
34. Enhanced adrenergic constriction of iliac artery with removal of endothelium in conscious dogs
35. Blood flow-and endotheliummediated vasomotion of iliac arteries in conscious dogs
36. Regulation of nitric oxide production in human coronary microvessels and the contribution of local kinin formation Circulation
37. 1-adrenoceptor agonist
38. Beta-adrenoceptor agonist mediated relaxation of rat isolated resistance arteries: A role for the endothelium and nitric oxide
39. Enhancement of the vasoconstrictor response to KCL by nitric oxide synthesis inhibition: A comparison with noradrenaline
40. 22adrenoceptor-mediated responses in the rabbit isolated pulmonary artery
41. Receptor-reserve and heterogeneity of vascular responses to vasodilator stimuli
42. 2-adrenergic agonists
43. Influence of the vascular endothelium on agonist-induced contractions and relaxations in rat aorta
44. Pertussis toxin inhibits endothelium-dependent relaxations to certain agonists in porcine coronary arteries
45. Natural Course of the impairment of endothelium-dependent relaxations after balloon endothelium-removal in porcine coronary arteries
46. Alpha-2 adrenoceptor subtype causing nitric oxide-mediated vascular relaxation in rats
47. Endotheliumdependent effects of carteolol
48. Stimulation of α2 adrenoceptors dilates the rat middle cerebral artery
49. Modulation of endotheliumderived nitric oxide in canine femoral veins
50. Endotheliumdependent relaxation by (x2-adrenoceptor agonists in spontaneously hypertensive rat aorta
51. Nitric oxide inhibits (x2-adrenoceptor-mediated endothelium-dependent vasodilation
52. Mechanisms of noradrenaline-induced vasorelaxation in isolated femoral arteries of the neonatal rat
53. Effects of dietary Larginine on the reactivity of canine coronary arteries
54. 2-adrenoceptor-mediated dilations in rat cerebral arteries
55. Binding and functional characterization of alpha-2 adrenergic receptor subtypes on pig vascular endothelium
56. Loss of endothelial pertussis toxin-sensitive G-protein function in atherosclerotic porcine coronary arteries
57. 2- and β-adrenergic responses in human forearm
58. G-proteins and endothelial responses
59. G Proteins and endothelium-dependent relaxations
60. Analysis of lysophosphatidylcholine-induced endothelial dysfunction
61. 2-adrenergic vasorelaxation by a pertussis toxin mechanism
62. Functional cross-talk between endothelial muscarinic and α2-adrenergic receptors in rabbit cerebral arteries
63. Impaired function of alpha-2 adrenoceptors in smooth muscle of mesenteric arteries from spontaneously hypertensive rats
64. Endotheliumdependent vasocontraction in response to noradrenaline in the canine cerebral artery
65. 2-adrenergic contributes to cerebral vasorelaxation
66. Control of vascular tone by endogenous endothelin-1 in human pial arteries
67. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
68. Production of endothelin by cultured porcine endothelial cells: Modulation by adrenaline
69. In vitro studies of release of adenine nucleotides and adenosine from rat vascular endothelium in response to α1adrenoceptor stimulation
70. Different P2purinergic receptor subtypes on endothelium and smooth muscle in canine blood vessels
71. Involvement of alpha-adrenoceptors in the endothelium-dependent depression of noradrenaline-induced contraction in rat aorta
72. Alpha-adrenoceptor stimulation of porcine pulmonary arteries
73. Noradrenaline, β-adrenoceptor mediated vasorelaxation and nitric oxide in large and small pulmonary arteries of the rat
74. Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries
75. Potentiation by trandolaprilat of the endothelium-dependent hyperpolarization induced by bradykinin
76. Endothelium-dependent responses and inhibition of angiotensin-converting enzyme
77. Acute exercise enhances receptor-mediated endothelium-dependent vasodilation by receptor upregulation
78. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries
79. Altered reactivity of coronary arteries located distal to a chronic coronary occlusion
80. 2-adrenoceptor antagonists evoke endothelium-dependent and -independent relaxations in the isolated rat aorta
81. Endothelium-removal decreases relaxations of canine coronary arteries caused by β-adrenergic agonists and adenosine
82. Enhanced relaxation response of canine coronary artery to isoproterenol and salbutamol after removal of endothelial cells
83. β-Adrenoceptors on endothelial cells do not influence release of relaxing factor in dog coronary arteries
84. Cyclic nucleotide interactions involved in endothelium-dependent dilatation in rat aortic rings
85. Involvement of endothelial cells in relaxation and contraction responses of the aorta to isoproterenol in naive and streptozotocin-induced diabetic rats
86. Novel signal transduction pathway mediating endothelium-dependent β-adrenoceptor vasorelaxation in rat thoracic aorta
87. Norepinephrineinduced relaxations in rat aorta mediated by endothelial beta adrenoceptors: Impairment by ageing and hypertension
88. Endotheliumdependent potentiation of the relaxation of the rat aorta to isoproterenol: Role of inhibition of cyclic AMP phosphodiesterase by cyclic GMP
89. Influence of endothelium on responses of isolated dog coronary artery to β-adrenoceptor agonists
90. β-adrenoceptor activates endothelium-dependent release of nitric oxide in rat aorta
91. A β-adrenoceptor agonist evokes a nitric oxide-cGMP relaxation mechanism modulated by adenylyl cyclase in rat aorta: Halothane does not inhibit this mechanism
92. Endothelium- and cytochrome P-450-dependent relaxation induced by isoproterenol in rat aortic rings
93. Modulation of cAMP-mediated vasorelaxation by endothelial nitric oxide and basal cGMP in vascular smooth muscle
94. Activation of nitric oxide synthase by beta2-adrenoceptors in human umbilical vein endothelium in vitro
95. Effects of propranolol and L-NAME on β-adrenoceptor-mediated relaxation in rat carotid artery
96. Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta
97. Role of endothelium/nitric oxide in atypical β-adrenoceptormediated relaxation in rat isolated aorta
98. β-adrenergic responses are significantly enhanced in rat carotid artery with intimal hyperplasia
99. Different mechanisms mediate β adrenoceptor stimulated vasorelaxation of coronary and femoral arteries
100. Prostacyclin releases endothelium-derived relaxing factor and potentiates its action in coronary arteries of the pig
101. Hypoxiainduced release of prostaglandins: Mechanisms and sources of production in coronary resistance vessels of the isolated rabbit heart
102. Celiprolol has no direct or indirect relaxing effects in isolated arteries and veins
103. Lack of importance of NO in β-adrenoceptor-mediated relaxation of large epicardial canine coronary arteries
104. Nitroprusside enhances isoprenaline-induces in cAMP in rat aortic smooth muscle
105. Synergistic actions of nitrovasodilators and isoprenaline on rat aortic smooth muscle
106. Effects of CD349 and 8-BRCGMP on isoproterenol-induced relaxation in rabbit aorta precontracted with endothelin-1
107. Characterization of β-adrenergic receptors in cultured human and bovine endothelial cells
108. Endothelial cells contain β adrenoceptors
109. Heterogeneous behavior of the canine arterial and venous wall: Importance of the endothelium
110. Neurogenic cholinergic prejunctional inhibition of sympathetic β-adrenergic relaxation in the canine coronary artery
111. Age-related involvement of the endothelium in β-adrenoceptor-mediated relaxation of rat aorta
112. Effect of cooling on β-receptor mechanisms in isolated cutaneous veins of the dog
113. Nitric oxide formation contributes to β-adrenergic dilation of resistance coronary vessels in conscious dogs
114. Role of nitric oxide in vasodilator response induced by salbutamol in rat diaphragmatic microcirculation
115. ATP channels and nitric oxide in conscious dogs
116. β-adrenoceptor dysfunction after inhibition of NO synthesis
117. 2-adrenergic stimulation or cyclic AMP elevation in vivo
118. Decreased vasodilator response to isoproterenol during nitric oxide inhibition in humans
119. Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by β-adrenergic agonists in human forearm
120. 2-adrenoceptor mediated vasodilatation in human forearm arterial vasculature
121. How to assess endothelial function in human blood vessels
122. Role of nitric oxide in isoprenaline and sodium nitroprusside-induced relaxation in human hand veins
123. How to assess endothelial function in human blood vessels
124. Enhancement effect of carteolol on the clonidine-induced vasodilation of rat mesenteric arteries
125. Nebivolol induces endothelium-dependent relaxations of canine coronary arteries
126. Nebivolol induces NO-mediated relaxations of rat small mesenteric but not of large elastic arteries
127. Inositol phosphate metabolism and nitric-oxide synthase activity in endothelial cells are involved in the vasorelaxant activity of nebivolol
128. Nebivolol: A third-generation β-blocker that augments vascular nitric oxide release
129. Nebivolol vasodilates human forearm vasculature: Evidence for an L-arginine/NO-dependent mechanism
130. The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension
131. The β adrenoceptor blocker tertatolol causes vasodilatation in the isolated perfused vasoconstricted rat kidney
132. Pharmacological features of the vasodilation induced by tertatolol in isolated perfused rat kidneys
133. 1A receptors
134. Effects of vasodilatory β-adrenoceptor antagonist on endotheliumderived nitric oxide release in rat kidney
135. 1adrenoceptor antagonist: Possible clinical relevance
136. Comparison of serotonergic receptor subtypes on the smooth muscle and endothelium of the canine coronary artery
137. Platelet-derived serotonin, the endothelium, and cardiovascular disease